期刊文献+

氯膦酸盐在恶性肿瘤治疗中的应用

The application of clodronate in cancer
下载PDF
导出
摘要 氯膦酸盐(clodronate)是一个不含氮的双膦酸盐类药物,它能够通过抑制破骨细胞的活性抑制骨质吸收,从而减少恶性肿瘤骨转移后的骨相关事件的发生率,治疗恶性肿瘤相关的骨痛和高钙血症,改善肿瘤或肿瘤治疗相关的骨质疏松情况。本文将对氯膦酸盐在恶性肿瘤治疗中的应用作一个回顾。 Clodronate is a non-nitriogen-containing bisphosphonate. It can inhibit osteoclast activity and thereby inhibit bone resorption. Clodronate can reduce the incidence of skeletal complications in patients with bone metastases and improve body mineral density losses resulting from cancer or anti-cancer treatment. This paper reviews the application of clodronate in cancer.
出处 《癌症进展》 2008年第1期21-23,共3页 Oncology Progress
关键词 氯膦酸盐 恶性肿瘤 clodronate Cancer
  • 相关文献

参考文献8

  • 1[1]Gulley J,Dahut WL.Clodronate in the prevention and treatment of skeletal metastasis.Expert Rev Anticancer Ther,2005,5 (2):221
  • 2[2]Rotstein S,Glas U,Eriksson M,er al.Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases-a prospective randomised placebo-controlled multicentre study.Eur J Cancer,1992,28A (4-5):890
  • 3[3]Dearnaley DP,Sydes MR,et al.A double -blind,placebo-controlled,randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).J Natl Cancer Inst,2003,95 (17):1300
  • 4[4]Saarto T,Vehmanen L,Virkkunen P,et al.Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node -positive breast cancer patients.Acta Oncol,2004,43 (7):650
  • 5[5]Ha TC,Li H.Meta-analysis of clodronate and breast cancer survival.Br J Cancer,2007,96 (12):1796
  • 6[6]Mason MD,Sydes MR,Glaholm J,et al.Oral sodium clodronate for nonmetastatic prostate cancer-results of a randomized double-blind placebo-controlled trial:Medical Research Council PR04 (ISRCTN61384873).J Natl Cancer Inst,2007,99 (10):765
  • 7[7]Saarto T,Vehmanen L,Elomaa I,et al.The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.BrJ Cancer,2001,84 (8):1047
  • 8[8]Dando TM,Wiseman LR.Clodronate:A review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer.Drugs Aging,2004,21(14):949

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部